Literature DB >> 3601379

[Primary reconstruction of injuries of the capsular ligament of the knee joint].

H Tscherne, P Lobenhoffer, M Blauth, R Hoffmann.   

Abstract

Whether operative or conservative treatment is indicated for acute knee ligament injuries depends on the lesions of the cruciate ligaments: complex instability with rupture of one or both cruciate ligaments and injuries to the lateral or medial ligamentous structures should be treated by operation. Surgical treatment of an isolated rupture of the anterior cruciate ligament is recommended only for the young active patient. Surgery is performed by way of a single anterolateral incision with standard medial and if necessary, lateral arthrotomies. Ruptures of the cruciate ligaments are reconstructed with absorbable sutures, which are passed through bone channels. Augmentation with an absorbable allograft is used in most reconstructions of the cruciate ligaments. A knee brace with limited range of motion is used for postoperative rehabilitation. Our long-term results after operative reconstruction of acute instabilities of the knee joint show that ligamentous stability was achieved in most cases, but the functional results were impaired by pain and limited range of motion.

Entities:  

Mesh:

Year:  1987        PMID: 3601379

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  3 in total

1.  [The value of sonographic diagnosis of the injured knee joint in trauma-surgical practice].

Authors:  C Ritzmann; F Weyand
Journal:  Unfallchirurgie       Date:  1992-08

2.  Posterior cruciate ligament (PCL) reconstruction--an in vitro study of isometry. Part I. Tests using a string linkage model.

Authors:  P Trus; J Petermann; L Gotzen
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1994       Impact factor: 4.342

3.  Anterior cruciate ligament suture in comparison with plasty. A 5-year follow-up study.

Authors:  D Träger; K Pohle; W Tschirner
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.